Nucleic acid reagents, including small interfering RNA (siRNA) and plasmid DNA, are important tools for the study of mammalian cells and are promising starting points for the development of new therapeutic agents. Realizing their full potential, however, requires nucleic acid delivery reagents that are simple to prepare, effective across many mammalian cell lines, and nontoxic. We recently described the extensive surface mutagenesis of proteins in a manner that dramatically increases their net charge. Here, we report that superpositively charged green fluorescent proteins, including a variant with a theoretical net charge of ؉36 (؉36 GFP), can penetrate a variety of mammalian cell lines. Internalization of ؉36 GFP depends on nonspecific electrostatic interactions with sulfated proteoglycans present on the surface of most mammalian cells. When ؉36 GFP is mixed with siRNA, protein-siRNA complexes Ϸ1.7 m in diameter are formed. Addition of these complexes to five mammalian cell lines, including four that are resistant to cationic lipid-mediated siRNA transfection, results in potent siRNA delivery. In four of these five cell lines, siRNA transfected by ؉36 GFP suppresses target gene expression. We show that ؉36 GFP is resistant to proteolysis, is stable in the presence of serum, and extends the serum half-life of siRNA and plasmid DNA with which it is complexed. A variant of ؉36 GFP can mediate DNA transfection, enabling plasmid-based gene expression. These findings indicate that superpositively charged proteins can overcome some of the key limitations of currently used transfection agents.cell-penetrating protein ͉ nucleic acid delivery C ommercially available cationic lipid reagents are typically used to transfect nucleic acids in mammalian cell culture. The effectiveness of these reagents, however, varies greatly by cell type. A number of cell lines, including some neuron, T cell, fibroblast, and epithelial cell lines, have demonstrated resistance to common cationic lipid transfection reagents (1-4). Alternative transfection approaches, including electroporation (5) and virus-mediated siRNA delivery (6, 7), have been used; however, these methods can be cytotoxic or perturb cellular function in unpredictable ways.Recent efforts to address the challenge of nucleic acid delivery have resulted in a variety of nucleic acid delivery platforms. These methods include lipidoids (8), cationic polymers (9), inorganic nanoparticles (10), carbon nanotubes (11), cell-penetrating peptides (12, 13), cationic protein-antibody fusions (14, 15), and chemically modified nucleic acids (16). Each of these methods offers benefits for particular applications; in most cases, however, questions regarding cytotoxicity, ease of preparation, stability, or generality across different cell lines remain. Easily prepared reagents capable of effectively delivering nucleic acids to a variety of cell lines without significant cytotoxicity therefore are of considerable interest.We recently described resurfacing proteins without abolishing their stru...